XML 60 R30.htm IDEA: XBRL DOCUMENT v2.4.0.6
Quarterly Financial Information
12 Months Ended
Mar. 31, 2012
Quarterly Financial Information [Abstract]  
Quarterly Financial Information

23. Quarterly Financial Information (Unaudited)

First   Second   Third   Fourth
(In millions, except per share amounts)   Quarter   Quarter   Quarter   Quarter
Fiscal 2012                
Revenues $ 29,980 $ 30,216 $ 30,839 $ 31,699
Gross profit   1,509   1,647   1,566   1,845
Net income (1)(2)   286   296   300   521
Earnings per common share (1)(2)(6)                
Diluted $ 1.13 $ 1.18 $ 1.20 $ 2.09
Basic   1.15   1.20   1.22   2.14
 
Fiscal 2011                
Revenues $ 27,450 $ 27,534 $ 28,247 $ 28,853
Gross profit   1,392   1,366   1,461   1,751
Net income (1)(3)(4)(5)   298   327   155   422
Earnings per common share (1)(3)(4)(5)(6)                
Diluted                
Continuing operations $ 1.10 $ 0.97 $ 0.60 $ 1.62
Discontinued operation (5)   0   0.28   0   0
Total $ 1.10 $ 1.25 $ 0.60 $ 1.62
Earnings per common share (1)(3)(4)(5)(6)                
Basic                
Continuing operations $ 1.12 $ 0.99 $ 0.61 $ 1.65
Discontinued operation (5)   0   0.28   0   0
Total $ 1.12 $ 1.27 $ 0.61 $ 1.65

 

(1) Financial results for the second, third and fourth quarters of 2012 include AWP litigation charges of $118 million pre-tax ($77 million after-tax), $27 million pre-tax ($15 million after-tax) and $4 million pre-tax (benefit of $32 million after-tax), which were recorded in operating expenses. Financial results for the second and third quarters of 2011 include AWP litigation charges of $24 million pre-tax ($16 million after-tax) and $189 million pre-tax ($133 million after-tax), which were recorded in operating expenses.

(2) Financial results for the third and fourth quarters of 2012 include product alignment charges of $42 million and $9 million.

 (3) Financial results for the first quarter of 2011 include the receipt of $51 million representing our share of a settlement of an antitrust class action lawsuit brought against a drug manufacturer, which was recorded as a reduction to cost of sales.

(4) Financial results for the second quarter of 2011 include a $72 million asset impairment charge for capitalized software held for sale, which was recorded to cost of sales.

(5) Financial results for the second quarter of 2011 include a $95 million pre-tax ($72 million after-tax) gain from the sale of MAP.

(6) Certain computations may reflect rounding adjustments.